A Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)

Clinical trial NCT06581198 · RECRUITING

Trial details

NCT number: NCT06581198
Sponsor: Novartis Pharmaceuticals
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lupus Erythematosus, Systemic Lupus Nephritis

Start date: 2024-09-04
Primary completion: 2028-02-14
Enrollment: 179

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.